腫瘤科

2025

Advancing precision therapy for colorectal cancer: Developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft models

Tang, Y. C., Ou, J. J., Hsu, S. C., Huang, C. H., Lin, L. M., Chang, H. H., Wang, Y. H., Huang, Z. T., Sun, M., Liu, K. J., Hung, Y. M., Lai, C. Y., Shih, C., Chen, C. T., Chang, J. Y., Hsieh, H. P., Jiaang, W. T. & Kuo, C. C., 2025 1月, 於: Pharmacological Research. 211, 107556.

研究成果: Article › 同行評審

A GAN-based with expert-validated data augmentation method for wireless capsule endoscopy images of small intestine polyp

Chou, Y. T., Hsieh, S. Y., Lin, P. C., Kuo, H. Y. & Chou, H. H., 2025 4月, 於: Journal of Supercomputing. 81, 5, 653.

研究成果: Article › 同行評審

Circulating tumor DNA methylation markers for the early diagnosis of hepatocellular carcinoma

Lu, C. Y., Tsai, K. F., Yen, C. J., Hsieh, C. J., Peng, P. J., Huang, S. C., Chuang, M. R. & Chu, C. J., 2025 12月, 於: Clinical and Experimental Medicine. 25, 1, 83.

研究成果: Article › 同行評審

Datopotamab Deruxtecan in Advanced or Metastatic Non–Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study

Sands, J., Ahn, M. J., Lisberg, A., Cho, B. C., Blumenschein, G., Shum, E., Tostivint, E. P., Goto, Y., Yoh, K., Heist, R., Shimizu, J., Lee, J. S., Baas, P., Planchard, D., Pérol, M., Felip, E., Su, W. C., Zebger-Gong, H., Lan, L. & Liu, C. 及其他3, Howarth, P., Chiaverelli, R. & Paz-Ares, L., 2025 4月, 於: Journal of Clinical Oncology. 43, 10, p. 1254-1265 12 p.

研究成果: Article › 同行評審

10 引文斯高帕斯（Scopus）

Deubiquitinase USP24 activated by IL-6/STAT3 enhances PD-1 protein stability and suppresses T cell antitumor response

Hsieh, H. C., Young, M. J., Chen, K. Y., Su, W. C., Lin, C. C., Yen, Y. T., Hung, J. J. & Wang, Y. C., 2025 4月 18, 於: Science Advances. 11, 16, eadt4258.

研究成果: Article › 同行評審

Durvalumab, Tremelimumab, and Platinum Chemotherapy in EGFR Mutation–Positive NSCLC: An Open-Label Phase 2 Trial (ILLUMINATE)

Lee, C. K., Liao, B. C., Subramaniam, S., Chiu, C. H., Mersiades, A. J., Ho, C. C., Brown, C., Lai, C. L., Hughes, B. G. M., Yang, T. Y., O'Byrne, K., Luo, Y. H., Yip, S., Ho, C. L., Bray, V., Su, W. C., Moore, M., Feng, W. L., Bai, Y. Y. & Ford, K. 及其他5, Cummins, M. M., Stockler, M. R., Solomon, B. J., John, T. & Chih-Hsin Yang, J., 2025 2月, 於: JTO Clinical and Research Reports. 6, 2, 100771.

研究成果: Article › 同行評審

Frailty and Intrinsic Capacity as Predictors of Recovery in Older Patients Surgically Treated for Cancer: A Longitudinal Study

Hu, F. W., Sun, C. Y., Su, W. C. & Chang, C. M., 2025, (Accepted/In press) 於: Cancer Nursing. 10.1097/NCC.0000000000001497.

研究成果: Article › 同行評審

Hijacking the hyaluronan assisted iron endocytosis to promote the ferroptosis in anticancer photodynamic therapy

Deng, H., Chen, J., Wang, H., Liu, R., Zhang, Y., Chang, H., Tung, C. H. & Zhang, W., 2025 3月 1, 於: Carbohydrate Polymers. 351, 123123.

研究成果: Article › 同行評審

1 引文斯高帕斯（Scopus）

Iron-Doxorubicin Hyaluronan Nanogel as an Effective Targeted Chemotherapy with Modulated Cardiotoxicity

Guo, H., Wang, H., Zhang, Y., Deng, H., Tung, C. H. & Zhang, W., 2025 3月 10, 於: Biomacromolecules. 26, 3, p. 1614-1626 13 p.

研究成果: Article › 同行評審

Nurses' intention and attitude to participate in advance care planning: An extended theory of planned behaviour using structural equation modelling–A cross-sectional study

Apiradee, Lin, C.-Y., Wirojratana, V., Lin, P. C. & Shu, B.-C., 2025 4月, 於: Journal of Clinical Nursing. 34, 4, p. 1364-1374 11 p.

研究成果: Article › 同行評審

1 引文斯高帕斯（Scopus）

Oral Cancer-Derived miR-762 Suppresses T-Cell Infiltration and Activation by Horizontal Inhibition of CXCR3 Expression

Peng, H. Y., Chang, C. W., Wu, P. H., Li, L. J., Lin, Y. L., Hsiao, M., Chang, J. Y., Chang, P. M. H., Lee, H. L. & Chang, W. M., 2025 2月, 於: International journal of molecular sciences. 26, 3, 1077.

研究成果: Article › 同行評審

Phase I study of oral metronomic gemcitabine (D07001) in patients with advanced solid tumors

Chiang, N. J., Lee, J. H., Chen, M. H., Chao, Y., Su, W. C., Bai, L. Y., Wu, S. Y., Hsu, C. H., Shan, Y. S., Li, C. P., Chen, S. H., Chung, W. P., Hao, W. H., Chen, L. T. & Lin, C. C., 2025 4月 1, 於: Oncologist. 30, 4, oyaf051.

研究成果: Article › 同行評審

Polygenic Risk Score and Lung Adenocarcinoma Risk Among Never-Smokers by EGFR Mutation Status: A Brief Report

Blechter, B., Hsiung, C. A., Wang, X., Zhang, H., Seow, W. J., Shi, J., Chatterjee, N., Kim, H. N., Wong, M. P., Hong, Y. C., Wong, J. Y. Y., Dai, J., Hosgood, H. D., Wang, Z., Chang, I. S., Choi, J., Wang, J., Song, M., Hu, W. & Zheng, W. 及其他132, Kim, J. H., Zhou, B., Albanes, D., Shin, M. H., Chung, L. P., An, S. J., Zheng, H., Yatabe, Y., Zhang, X. C., Kim, Y. T., Shu, X. O., Kim, Y. C., Vermeulen, R. C. H., Bassig, B. A., Chang, J., Man Ho, J. C., Ji, B. T., Kubo, M., Daigo, Y., Momozawa, Y., Kamatani, Y., Honda, T., Kunitoh, H., Watanabe, S. I., Miyagi, Y., Nakayama, H., Matsumoto, S., Tsuboi, M., Goto, K., Yin, Z., Takahashi, A., Goto, A., Minamiya, Y., Shimizu, K., Tanaka, K., Wu, T., Wei, F., Su, J., Kim, Y. H., Oh, I. J., Fun Lee, V. H., Su, W. C., Chen, Y. M., Chang, G. C., Chen, K. Y., Huang, M. S., Lin, H. C., Seow, A., Park, J. Y., Kweon, S. S., Chen, C. J., Gao, Y. T., Wu, C., Qian, B., Lu, D., Liu, J., Jeon, H. S., Hsiao, C. F., Sung, J. S., Tsai, Y. H., Jung, Y. J., Guo, H., Hu, Z., Chen, T. Y., Burdett, L., Yeager, M., Hutchinson, A., Berndt, S. I., Wu, W., Wang, J., Choi, J. E., Park, K. H., Sung, S. W., Liu, L., Kang, C. H., Chen, C. H., Xu, J., Guan, P., Tan, W., Wang, C. L., Loon Sihoe, A. D., Chen, Y., Choi, Y. Y., Kim, J. S., Yoon, H. I., Cai, Q., Park, I. K., Xu, P., He, Q., Chen, C. Y., Wu, J., Lim, W. Y., Chen, K. C., Chan, J. K. C., Li, J., Chen, H., Yu, C. J., Jin, L., Fraumeni, J. F., Liu, J., Landi, M. T., Yamaji, T., Yang, Y., Hicks, B., Wyatt, K., Li, S. A., Ma, H., Song, B., Wang, Z., Cheng, S., Li, X., Ren, Y., Iwasaki, M., Zhu, J., Jiang, G., Fei, K., Wu, G., Chien, L. H., Tsai, F. Y., Yu, J., Stevens, V. L., Yang, P. C., Lin, D., Chen, K., Wu, Y. L., Matsuo, K., Rothman, N., Shiraishi, K., Shen, H., Chanock, S. J., Kohno, T. & Lan, Q., 2025 4月, 於: Journal of Thoracic Oncology. 20, 4, p. 521-530 10 p.

研究成果: Article › 同行評審

Second harmonic generation microscopy reveals the spatial orientation of glutamine-potentiated liver regeneration after hepatectomy

Yen, C. C., Yen, C. S., Tsai, H. W., Yeh, M. M., Hong, T. M., Wang, W. L., Liu, I. T., Shan, Y. S. & Yen, C. J., 2025 3月 7, 於: Hepatology Communications. 9, 3, e0640.

研究成果: Article › 同行評審

Sunvozertinib monotherapy in EGFR tyrosine kinase inhibitor-resistant non-small cell lung cancer with EGFR mutations

Wang, M., Xu, Y., Huang, W. T., Su, W. C., Gao, B., Lee, C. K., Fang, J., Zhu, X., Yang, Z., Jänne, P. A. & Yang, J. C. H., 2025 1月, 於: Lung Cancer. 199, 108053.

研究成果: Article › 同行評審

2 引文斯高帕斯（Scopus）

Synthesis, Anticancer Evaluation and Structure–Activity Relationship of Taiwanin a Derivatives

Chang, C. I., Kuo, C. C., Wein, Y. S., Chao, C. Y., Chen, Y. C., Chang, J. Y. & Kuo, Y. H., 2025 1月, 於: Chemistry of Natural Compounds. 61, 1, p. 11-18 8 p.

研究成果: Article › 同行評審

The miR-876-5p/SOCS4/STAT3 pathway induced the expression of PD-L1 and suppressed antitumor immune responses

Peng, H. Y., Huang, Y. L., Wu, P. H., Li, L. J., Peng, B. Y., Wu, C. Y., Lin, Y. L., Hsiao, M., Chang, J. Y., Mu-Hsin Chang, P., Lee, H. L. & Chang, W. M., 2025 12月, 於: Cancer Cell International. 25, 1, 114.

研究成果: Article › 同行評審

Tumor cell-derived ISG15 promotes fibroblast recruitment in oral squamous cell carcinoma via CD11a-dependent glycolytic reprogramming

Wang, S. H., Chen, Y. L., Huang, S. H., Fu, Y. K., Lin, S. F., Jiang, S. S., Liu, S. C., Hsiao, J. R., Chang, J. Y. & Chen, Y. W., 2025 12月, 於: Oncogenesis. 14, 1, 6.

研究成果: Article › 同行評審

Upregulation of Cathepsin S Expression Contributes to Neuronal Damage Following Kainic Acid–Induced Status Epilepticus

Shih, H. L., Cheng, K. H., Chen, C. H., Chang, J. Y. & Hsu, K. S., 2025 3月, 於: Journal of Neurochemistry. 169, 3, e70037.

研究成果: Article › 同行評審

‘Regrets become a lasting source of pain’: A qualitative study on family caregivers’ experiences leading up to a relative’s death

Liang, H. J., Xiong, Q., Lin, P. C., Tsai, J. H. & Preston, N., 2025 3月, 於: Palliative Medicine. 39, 3, p. 401-412 12 p.

研究成果: Article › 同行評審

2024

A computed tomography radiomics-based model for predicting osteoporosis after breast cancer treatment

Lai, Y. H., Tsai, Y. S., Su, P. F., Li, C. I. & Chen, H. H. W., 2024 3月, 於: Physical and Engineering Sciences in Medicine. 47, 1, p. 239-248 10 p.

研究成果: Article › 同行評審

1 引文斯高帕斯（Scopus）

An Innovative Multi-Omics Model Integrating Latent Alignment and Attention Mechanism for Drug Response Prediction

Chen, H.-O., Cui, Y.-C., Lin, P.-C. & Chiang, J.-H., 2024, 於: Journal of Personalized Medicine. 14, 7, p. 694

研究成果: Article › 同行評審

2 引文斯高帕斯（Scopus）

A phase 1 study of biweekly nab-paclitaxel/ oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers:TCOGT1216 study

Tsai, H. J., Yang, S. H., Hsiao, C. F., Kao, H. F., Su, Y. Y., Shan, Y. S., Yen, C. J., Du, J. S., Hsu, C., Wu, I. C. & Chen, L. T., 2024 10月, 於: Oncologist. 29, 10, p. e1396-e1405

研究成果: Article › 同行評審

A rare case of an endobronchial mass due to Neurospora intermedia

Wu, W. L., Lee, J. C., Su, W. C., Wang, S. Y. & Wu, C. J., 2024 9月, 於: International Journal of Infectious Diseases. 146, 107119.

研究成果: Article › 同行評審

開啟存取

Betel-nut chewing does not influence PD-L1 expression rates in recurrent/metastatic head and neck squamous cell carcinoma (HNSCC): A prospective biomarker prevalence study

Hong, R. L., Yen, C. J., Lien, M. Y., Cheng, R., Su, Y. W., Lin, H. N., Poon, S. L. & Chien, C. Y., 2024 5月, 於: Oral Oncology. 152, 106760.

研究成果: Letter › 同行評審

2 引文斯高帕斯（Scopus）

Carbon Dot Micelles Synthesized from Leek Seeds in Applications for Cobalt (II) Sensing, Metal Ion Removal, and Cancer Therapy

Tsai, T. H., Lo, W., Wang, H. Y. & Tsai, T. L., 2024 11月, 於: Journal of Functional Biomaterials. 15, 11, 347.

研究成果: Article › 同行評審

開啟存取

CD44-hyaluronan mediating endocytosis of iron-platinum alloy nanoparticles induces ferroptotic cell death in mesenchymal-state lung cancer cells with tyrosine kinase inhibitor resistance

Tsai, T., Wu, S., Lai, Y., Wang, H., Hou, P., Huang, Y., Chen, H. H. & Su, W., 2024 9月 15, 於: Acta Biomaterialia. 186, p. 396-410 15 p.

研究成果: Article › 同行評審

3 引文斯高帕斯（Scopus）

Cetuximab Treatment beyond Progression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Nationwide Population-Based Study (THNS-2021-08)

Wang, H. M., Lou, P. J., Yang, M. H., Chen, T. H., Lien, M. Y., Lin, J. C., Chen, J. P., Lu, W. C., Lu, H. J., Huang, T. L., Yen, C. J., Wu, S. Y., Wang, H. C. & Hsieh, M. C., 2024 1月, 於: Targeted Oncology. 19, 1, p. 51-58 8 p.

研究成果: Article › 同行評審

開啟存取

1 引文斯高帕斯（Scopus）

Clinical outcomes of cetuximab-based treatment for distant metastatic head and neck squamous cell carcinoma: A real-world study using Taiwan Head Neck Society registry database

Lu, H. J., Hsieh, M. C., Wang, H. M., Hsieh, J. C. H., Yen, C. J., Wu, S. Y., Huang, H. C., Wang, H. C., Chu, P. Y., Chen, T. H., Chien, C. Y., Huang, T. L., Chang, Y. F., Hua, C. H., Lien, M. Y., Chen, J. P., Lu, W. C., Lin, J. C., Wang, C. C. & Liu, Y. C. 及其他2, Yang, M. H. & Lou, P. J., 2024 5月, 於: Head and Neck. 46, 5, p. 1063-1073 11 p.

研究成果: Article › 同行評審

Clinical practice consensus for the diagnosis and management of melanoma in Taiwan

Wu, C. E., Liao, Y. H., Wu, C. L., Yen, R. F., Lin, C. C., Yang, M. H., Yen, C. C., Su, W. C., Yen, C. J., Chang, Y. F., Wu, M. F., Yang, Y., Lin, C. Y., Yang, W. C., Wang, H. C., Li, C. Y., Ho, Y. Y., Chang, Y. Y., Wu, C. S. & Hsu, H. C. 及其他10, Chen, K. H., Huang, Y., Chen, C. J., Chuang, P. J., Lai, Y. C., Huang, Y. Y., Tseng, N. C., Huang, Y. T., Chu, C. Y. & Wen-Cheng Chang, J., 2024 1月, 於: Journal of the Formosan Medical Association. 123, 1, p. 7-15 9 p.

研究成果: Article › 同行評審

開啟存取

3 引文斯高帕斯（Scopus）

Comparison of therapeutic outcomes in esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy: A prospective observational cohort study

Liu, Y. W., Lee, J. Y., Wang, Y. K., Chen, Y. H., Fang, P. T., Chou, S. H., Chen, M. H., Bai, L. Y., Yen, C. J., Wu, M. T. & Wu, I. C., 2024 1月, 於: Journal of the Formosan Medical Association. 123, 1, p. 106-115 10 p.

研究成果: Article › 同行評審

開啟存取

2 引文斯高帕斯（Scopus）

Correction: IL-33/NF-κB/ST2L/Rab37 positive-feedback loop promotes M2 macrophage to limit chemotherapeutic efficacy in lung cancer (Cell Death & Disease, (2024), 15, 5, (356), 10.1038/s41419-024-06746-y)

Yang, Y. E., Hu, M. H., Zeng, Y. C., Tseng, Y. L., Chen, Y. Y., Su, W. C., Chang, C. P. & Wang, Y. C., 2024 8月, 於: Cell Death and Disease. 15, 8, 629.

研究成果: Comment/debate › 同行評審

Correction: PTPN23 ubiquitination by WDR4 suppresses EGFR and c-MET degradation to define a lung cancer therapeutic target (Cell Death & Disease, (2023), 14, 10, (671), 10.1038/s41419-023-06201-4)

Singh, S., Yeat, N. Y., Wang, Y. T., Lin, S. Y., Kuo, I. Y., Wu, K. P., Wang, W. J., Wang, W. C., Su, W. C., Wang, Y. C. & Chen, R. H., 2024 7月, 於: Cell Death and Disease. 15, 7, 468.

研究成果: Comment/debate › 同行評審

開啟存取

Defective N-glycosylation of IL6 induces metastasis and tyrosine kinase inhibitor resistance in lung cancer

Hung, C. H., Wu, S. Y., Yao, C. I. D., Yeh, H. H., Lin, C. C., Chu, C. Y., Huang, T. Y., Shen, M. R., Lin, C. H. & Su, W. C., 2024 12月, 於: Nature communications. 15, 1, 7885.

研究成果: Article › 同行評審

10 引文斯高帕斯（Scopus）

Downregulation of microRNA-326 enhances ZNF322A expression, transcriptional activity and tumorigenic effects in lung cancer

Huang, S. H., Hsieh, H. C., Shieh, J. M., Su, W. C. & Wang, Y. C., 2024 1月 1, 於: BioFactors. 50, 1, p. 214-227 14 p.

研究成果: Article › 同行評審

1 引文斯高帕斯（Scopus）

Elastic and Self-Healing Copolymer Coatings with Antimicrobial Function

Laysandra, L., Rusli, R. A., Chen, Y. W., Chen, S. J., Yeh, Y. W., Tsai, T. L., Huang, J. H., Chuang, K. S., Njotoprajitno, A. & Chiu, Y. C., 2024 5月 15, 於: ACS Applied Materials and Interfaces. 16, 19, p. 25194-25209 16 p.

研究成果: Article › 同行評審

開啟存取

3 引文斯高帕斯（Scopus）

Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial

Park, J. O., Feng, Y. H., Su, W. C., Oh, D. Y., Keam, B., Shen, L., Kim, S. W., Liu, X., Liao, H., Qing, M., Zhang, C., Qian, J., Tang, X., Li, P., Triantos, S. & Sweiti, H., 2024 12月, 於: BMC cancer. 24, 1, 1006.

研究成果: Article › 同行評審

4 引文斯高帕斯（Scopus）

Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial

Grivas, P., Garralda, E., Meric-Bernstam, F., Mellinghoff, I. K., Goyal, L., Harding, J. J., Dees, E. C., Bahleda, R., Azad, N. S., Karippot, A., Kurzrock, R., Tabernero, J., Kononen, J., Ng, M. C. H., Mehta, R., Uboha, N. V., Bigot, F., Boni, V., Bowyer, S. E. & Breder, V. 及其他21, Cervantes, A., Chan, N., Cleary, J. M., Dhawan, M., Eefsen, R. L., Ewing, J., Graham, D. M., Guren, T. K., Kim, J. W., Koynov, K., Oh, D. Y., Redman, R., Yen, C. J., Spetzler, D., Roubaudi-Fraschini, M. C., Nicolas-Metral, V., Ait-Sarkouh, R., Zanna, C., Ennaji, A., Pokorska-Bocci, A. & Flaherty, K. T., 2024 10月 15, 於: Clinical Cancer Research. 30, 20, p. 4572-4583 12 p.

研究成果: Article › 同行評審

2 引文斯高帕斯（Scopus）

Germline MLH1 and MSH6 mutations from two Lynch syndrome families identified in a patient with early-onset of endometrial cancer: A case report

Huang, Y. C., Lin, P. C., Wu, P. Y., Chen, N. S., Shen, M. R., Yeh, Y. M. & Cheng, Y. M., 2024 6月, 於: Gynecologic Oncology Reports. 53, 101381.

研究成果: Article › 同行評審

開啟存取

Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan

Cheng, S. M., Su, Y. Y., Chiang, N. J., Wang, C. J., Chao, Y. J., Huang, C. J., Tsai, H. J., Chen, S. H., Chang, C. Y., Tsai, C. R., Li, Y. J., Yen, C. J., Chuang, S. C., Chang, J. S. M., Shan, Y. S., Hwang, D. Y. & Chen, L. T., 2024 12月, 於: Journal of biomedical science. 31, 1, 21.

研究成果: Article › 同行評審

開啟存取

4 引文斯高帕斯（Scopus）

IL-33/NF-κB/ST2L/Rab37 positive-feedback loop promotes M2 macrophage to limit chemotherapeutic efficacy in lung cancer

Yang, Y. E., Hu, M. H., Zeng, Y. C., Tseng, Y. L., Chen, Y. Y., Su, W. C., Chang, C. P. & Wang, Y. C., 2024 5月, 於: Cell Death and Disease. 15, 5, 356.

研究成果: Article › 同行評審

開啟存取

6 引文斯高帕斯（Scopus）

Impact of previous S-1 treatment on efficacy of liposomal irinotecan plus 5-fluorouracil and leucovorin in patients with metastatic pancreatic cancer

Tang, C. Y., Yang, S. H., Li, C. P., Su, Y. Y., Chiu, S. C., Bai, L. Y., Shan, Y. S., Chen, L. T., Chuang, S. C., Chan, D. C., Yen, C. J., Peng, C. M., Chiu, T. J., Chen, Y. Y., Chen, J. S., Chiang, N. J. & Chou, W. C., 2024 6月, 於: Pancreatology. 24, 4, p. 600-607 8 p.

研究成果: Article › 同行評審

Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study

TALENT Investigators, 2024 2月, 於: The Lancet Respiratory Medicine. 12, 2, p. 141-152 12 p.

研究成果: Article › 同行評審

69 引文斯高帕斯（Scopus）

Macrophage-mediated controlled release of cysteine protease inhibitor from PLGA-PEG/hydroxyapatite microspheres for targeting cathepsin S in Alzheimer's disease

Yang, I. H., Kuan, C. Y., Zhang, S. L., Chen, Z. Y., Li, C. H., Liang, Y. J., Kuo, W. T., Chang, C. T., Lin, J., Hsieh, H. P., Chang, J. Y. & Lin, F. H., 2024 6月 24, 於: European Polymer Journal. 214, 113151.

研究成果: Article › 同行評審

3 引文斯高帕斯（Scopus）

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial

KEYNOTE-412 Investigators, 2024 5月, 於: The Lancet Oncology. 25, 5, p. 572-587 16 p.

研究成果: Article › 同行評審

70 引文斯高帕斯（Scopus）

Pembrolizumab with platinum-based chemotherapy with or without epacadostat as first-line treatment for metastatic non-small cell lung cancer: a randomized, partially double-blind, placebo-controlled phase II study

Boyer, M., Hui, R., Urban, D., Clingan, P., Su, W. C., Devaux, C., Gadgeel, S., Garassino, M., Leopold, L., Daniel, J., Munteanu, M. C., Samkari, A., Luo, Y. & Abreu, D. R., 2024 7月, 於: BMC cancer. 23, Suppl 1, 1250.

研究成果: Article › 同行評審

開啟存取

1 引文斯高帕斯（Scopus）

Phase I–II study of OBI-888, a humanized monoclonal IgG1 antibody against the tumor-associated carbohydrate antigen Globo H, in patients with advanced solid tumors

Tsimberidou, A. M., Grothey, A., Sigal, D., Lenz, H. J., Hochster, H. S., Chao, Y., Bai, L. Y., Yen, C. J. L., Xu, D. & Saville, M. W., 2024 12月, 於: Cancer Chemotherapy and Pharmacology. 94, 6, p. 787-798 12 p.

研究成果: Article › 同行評審

Prognostic factors and risk-stratification model of recurrent or metastatic head and neck squamous cell carcinoma treated with cetuximab containing regimen

Yang, M. H., Chen, T. H., Wang, H. M., Hsieh, J. C. H., Huang, H. C., Hsieh, M. C., Yen, C. J., Wu, S. Y., Hua, C. H., Lien, M. Y., Chang, Y. F., Wang, H. C., Chien, C. Y., Huang, T. L., Lu, H. J., Lin, J. C., Wang, C. C., Liu, Y. C., Chen, J. P. & Lu, W. C. 及其他4, Yiu, C. Y., Lin, C. L., Lou, P. J. & Chu, P. Y., 2024 12月, 於: BMC cancer. 24, 1, 1227.

研究成果: Article › 同行評審

Rab37 mediates trafficking and membrane presentation of PD-1 to sustain T cell exhaustion in lung cancer

Kuo, W. T., Kuo, I. Y., Hsieh, H. C., Wu, S. T., Su, W. C. & Wang, Y. C., 2024 12月, 於: Journal of biomedical science. 31, 1, 20.

研究成果: Article › 同行評審

開啟存取

4 引文斯高帕斯（Scopus）

Real-World Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific Countries

Lee, C. K., Yoo, C., Hong, J. Y., Park, S. J., Kim, J. W., Tai, D. W. M., Kim, H., Korphaisarn, K., Tanasanvimon, S., Chen, S. C., Kim, J. W., Kim, I., Kim, M., Choo, J., Oh, S. B., Chen, C. T., Bae, W. K., Kim, H., Huh, S. J. & Yen, C. J. 及其他10, Park, S., Lee, D. K., Chan, L. L., Kang, B., Kang, M., Sundar, R., Choi, H. J., Chan, S. L., Chon, H. J. & Lee, M. A., 2024, (Accepted/In press) 於: Liver Cancer.

研究成果: Article › 同行評審

4 引文斯高帕斯（Scopus）

研究成果

搜尋結果